Inhibrx Biosciences, Inc. INBX

Set alert

Price alert · INBX

All alert types
72.16 USD +0.38 +0.53%

At close · Nov 2

72.16 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
72.00 × 2
Ask
72.26 × 2
70.87 Day range 73.49
58.39 52-week range 141.84
YTD
-8.66%
1 year
-11.63%
Open
72.45
Prev close
71.78
Mkt cap
1.06B
Vol
234.38K
Avg vol
301.77K
EPS
-8.88
P/E
0.00
Div yield
0.00%
More statistics
Low
70.87
High
73.49
Forward P/E
-8.24
Beta
4.04
Short ratio
13.62
Inst. own
90.71%
Dividend
0.00
Ex-div date
Earnings
Nov 13, 2026
50-d avg
102.34
200-d avg
92.14
1y target
266.67

5D chart

Chart tools
Interval

Signals (108)
NameTimeAgo
RSI: OverboughtOct 30, 3:45 PM3 days ago
SMA: BullishOct 30, 3:20 PM3 days ago
SMA: BullishOct 30, 3:05 PM3 days ago
MACD: Buy SignalOct 30, 3:05 PM3 days ago
RSI: OversoldOct 30, 2:45 PM3 days ago
SMA: BearishOct 30, 2:25 PM3 days ago
SMA: BullishOct 30, 2:20 PM3 days ago
SMA: BearishOct 30, 1:40 PM3 days ago
MACD: Sell SignalOct 30, 1:40 PM3 days ago
SMA: BullishOct 30, 1:35 PM3 days ago
MACD: Buy SignalOct 30, 1:30 PM3 days ago
SMA: BearishOct 30, 1:25 PM3 days ago
SMA: BullishOct 30, 1:15 PM3 days ago
MACD: Sell SignalOct 30, 12:50 PM3 days ago
SMA: BearishOct 30, 12:45 PM3 days ago
SMA: BullishOct 30, 12:40 PM3 days ago
SMA: BearishOct 30, 12:30 PM3 days ago
SMA: BearishOct 30, 12:25 PM3 days ago
SMA: BearishOct 30, 12:00 PM3 days ago
SMA: BearishOct 30, 12:00 PM3 days ago

Newest 20 of 108.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 266.67 +269.5% upside
Target (low)
230.00
Target (mean)
266.67
Target (high)
325.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy3
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

INBX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-2.36-2.57 – -2.14-2.28-3.3%00.0%2
Next quarter-2.42-2.53 – -2.30-2.11-14.4%00.0%2
Current year-9.26-9.58 – -8.93-9.04-2.4%0-100.0%2
Next year-8.76-9.05 – -8.47-9.26+5.3%36.05M0.0%2

Upgrades and downgrades

The latest rating changes

INBX analyst upgrades and downgrades
DateFirmActionFromTo
Aug 24, 2026HC Wainwright & Co.Initiated—Buy
Apr 8, 2026StifelInitiated—Buy
Aug 22, 2025JMP SecuritiesReiteratedMarket PerformMarket Perform
May 15, 2025JMP SecuritiesReiteratedMarket PerformMarket Perform
Mar 18, 2025Citizens Capital MarketsReiteratedMarket PerformMarket Perform
Jan 22, 2025JMP SecuritiesReiteratedMarket PerformMarket Perform
Jul 23, 2024JMP SecuritiesInitiated—Market Perform
Jan 23, 2024JMP SecuritiesDowngradeMarket OutperformMarket Perform
Nov 20, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Aug 23, 2023JMP SecuritiesMaintainedOutperformOutperform
May 10, 2023JMP SecuritiesReiterated—Market Outperform
Mar 8, 2023JMP SecuritiesMaintained—Market Outperform
Mar 7, 2023Credit SuisseReiterated—Outperform
Nov 8, 2022Credit SuisseMaintained—Outperform
Oct 5, 2022Evercore ISI GroupMaintained—Outperform
Aug 9, 2022Credit SuisseMaintained—Outperform
Mar 16, 2022SMBC NikkoInitiated—Outperform
Mar 2, 2022JMP SecuritiesMaintained—Market Outperform
Nov 10, 2021Credit SuisseMaintained—Outperform
Nov 2, 2021JMP SecuritiesMaintained—Market Outperform
Sep 21, 2021JMP SecuritiesInitiated—Market Outperform
Sep 14, 2020JefferiesInitiated—Buy
Sep 14, 2020Evercore ISI GroupInitiated—Outperform
Sep 14, 2020Credit SuisseInitiated—Outperform